Inhibition of liver glutathione S-transferase activity in rats by hypolipidemic drugs related or unrelated to clofibrate

This publication has 35 references indexed in Scilit:

• Impairment of hepatic glutathione S-transferase activity as a cause of reduced biliary sulfobromophthalein excretion in clofibrate-treated rats
  Biochemical Pharmacology, 1984
• Effect of Clofibrate on the Metabolism of Bilirubin, Bromosulphophthalein and Indocyanine Green and on the Biliary Lipid Composition in Gilbert's Syndrome
  Clinical Science, 1984
• Effects of benfluorex and fenofibrate treatment on mitochondrial and peroxisomal marker enzymes in rat liver
  Biochemical Pharmacology, 1984
• Influence of clofibrate on hepatic transport of bilirubin and bromosulfophthalein in rats
  Biochemical and Biophysical Research Communications, 1979
• Enhancement of Fatty Acyl-CoA Oxidizing Activity in Rat Liver Peroxisomes by Di-(2-Ethylhexyl)Phthalate
  The Journal of Biochemistry, 1978
• Three Hypolipidemic Drugs Increase Hepatic Palmitoyl-Coenzyme A Oxidation in the Rat
  Science, 1977
• Increase in the hepatic glucuronidation and clearance of bilirubin in clofibrate-treated rats
  Biochemical Pharmacology, 1977
• Studies on the hepatomegaly caused by the hypolipidemic drugs nafenopin and clofibrate
  Toxicology and Applied Pharmacology, 1972
• RESPONSE OF HEPATIC MICROBODIES TO A HYPOLIPIDEMIC AGENT, ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB)
  The Journal of cell biology, 1966
• NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT
  Nature, 1965